137 related articles for article (PubMed ID: 12098525)
1. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Gimeno P; Besacier F; Chaudron-Thozet H; Girard J; Lamotte A
Forensic Sci Int; 2002 Jun; 127(1-2):1-44. PubMed ID: 12098525
[TBL] [Abstract][Full Text] [Related]
2. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
3. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in The Netherlands.
van Deursen MM; Lock ER; Poortman-van der Meere AJ
Sci Justice; 2006; 46(3):135-52. PubMed ID: 17388242
[TBL] [Abstract][Full Text] [Related]
4. Impurity profiling of seized MDMA tablets by capillary gas chromatography.
Palhol F; Boyer S; Naulet N; Chabrillat M
Anal Bioanal Chem; 2002 Sep; 374(2):274-81. PubMed ID: 12324849
[TBL] [Abstract][Full Text] [Related]
5. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase extraction for profiling of ecstasy tablets.
Rashed AM; Anderson RA; King LA
J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.
Poetzsch M; Steuer AE; Hysek CM; Liechti ME; Kraemer T
Drug Test Anal; 2016 Feb; 8(2):235-40. PubMed ID: 25990956
[TBL] [Abstract][Full Text] [Related]
8. The identification of a chlorinated MDMA.
Maresova V; Hampl J; Chundela Z; Zrcek F; Polasek M; Chadt J
J Anal Toxicol; 2005; 29(5):353-8. PubMed ID: 16105260
[TBL] [Abstract][Full Text] [Related]
9. Rapid analysis of 3,4-methylenedioxymethamphetamine: a comparison of nonaqueous capillary electrophoresis/fluorescence detection with GC/MS.
Fang C; Chung YL; Liu JT; Lin CH
Forensic Sci Int; 2002 Feb; 125(2-3):142-8. PubMed ID: 11909656
[TBL] [Abstract][Full Text] [Related]
10. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
11. Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users.
Rothe M; Pragst F; Spiegel K; Harrach T; Fischer K; Kunkel J
Forensic Sci Int; 1997 Sep; 89(1-2):111-28. PubMed ID: 9306670
[TBL] [Abstract][Full Text] [Related]
12. Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Gimeno P; Besacier F; Chaudron-Thozet H
Forensic Sci Int; 2003 Apr; 132(3):182-94. PubMed ID: 12711203
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ecstasy tablets using capillary electrophoresis with capacitively coupled contactless conductivity detection.
Porto SK; Nogueira T; Blanes L; Doble P; Sabino BD; do Lago CL; Angnes L
J Forensic Sci; 2014 Nov; 59(6):1622-6. PubMed ID: 25039689
[TBL] [Abstract][Full Text] [Related]
14. 15N isotopic analyses: a powerful tool to establish links between seized 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Palhol F; Lamoureux C; Naulet N
Anal Bioanal Chem; 2003 Jun; 376(4):486-90. PubMed ID: 12819848
[TBL] [Abstract][Full Text] [Related]
15. The profiling of MDMA tablets: a study of the combination of physical characteristics and organic impurities as sources of information.
Milliet Q; Weyermann C; Esseiva P
Forensic Sci Int; 2009 May; 187(1-3):58-65. PubMed ID: 19345026
[TBL] [Abstract][Full Text] [Related]
16. Fingerprinting of 3, 4-methylenedioxymethamphetamine markers by desorption/ionization on porous silicon.
Kraj A; Swist M; Strugała A; Parczewski A; Silberring J
Eur J Mass Spectrom (Chichester); 2006; 12(4):253-9. PubMed ID: 17057282
[TBL] [Abstract][Full Text] [Related]
17. Validation of an HPLC method for quantitation of MDMA in tablets.
Müller IB; Windberg CN
J Chromatogr Sci; 2005 Sep; 43(8):434-7. PubMed ID: 16212786
[TBL] [Abstract][Full Text] [Related]
18. mCPP: an undesired addition to the ecstasy market.
Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
[TBL] [Abstract][Full Text] [Related]
19. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a rapid oral fluid point-of-care test for MDMA.
Wilson L; Jehanli A; Hand C; Cooper G; Smith R
J Anal Toxicol; 2007 Mar; 31(2):98-104. PubMed ID: 17536745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
